Top

Resverlogix Corp.

TSX Exchange | Aug 17, 2019, 1:57 PM EDT | Real-time price

RVX $ 2.76 RT
CHANGE
0.02 (0.73%)
VOLUME
21,975
Day Low: 2.74
Day High: 2.80

Company Profile for Resverlogix Corp.

Description & Contact Information
Business Description

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Address
4820 Richard Road S.W., Suite 300, Calgary, AB, CAN, T3E 6L1
Telephone
+1 403 254-9252
Facsimile
+1 403 256-8495
Fiscal Year End
04/2019
Industry Classifications
Sector
Healthcare
CIK
1372821
Industry
Biotechnology
SIC
3741
NAICS
Biological Product (except Diagnostic) Manufacturing(325414)
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Profiles by Morningstar. See the QuoteMedia Terms of Use.